[Clinical action of a sedative neuroleptic (cyamepromazine)].
D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004123:Dimethylamines / Q000009:adverse effects / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D009570:Nitriles / Q000009:adverse effects / Q000627:therapeutic use; D010640:Phenothiazines; D011618:Psychotic Disorders / Q000188:drug therapy*
D014150:Antipsychotic Agents; D004123:Dimethylamines; D009570:Nitriles; D010640:Phenothiazines
Action clinique d'un neuroleptique sédatif (la cyamépromazine.